Table 3 Therapeutic effect of apatinib in different cancers
Tumor type | n | Efficacy evaluable number | PR(%) | SD(%) | PD(%) |
|---|---|---|---|---|---|
Breast cancer | 10 | 7 | 1(14.3) | 3(42.8) | 3(42.9) |
NSCLC | 2 | 2 | 1(50.0) | 1(50.0) | 0 |
Liver cancer | 3 | 2 | 0 | 0 | 2(100.0) |
Cervical cancer | 1 | 1 | 0 | 1(100.0) | 0 |
Osteosarcoma | 1 | 1 | 0 | 0 | 1(100.0) |
Soft tissue sarcoma | 2 | 2 | 0 | 2(100.0) | 0 |
Colorectal cancer | 7 | 6 | 0 | 4(66.7) | 2(33.3) |
Ovarian cancer | 1 | 1 | 0 | 0 | 1(100.0) |
Neuroendocrine carcinoma | 3 | 3 | 1(33.3) | 2(66.7) | 0 |
Gastric cancer | 5 | 3 | 1(33.3) | 2(66.7) | 0 |
Pancreatic cancer | 1 | 1 | 0 | 0 | 1(100.0) |
Metastatic adenocarcinoma | 1 | 1 | 0 | 0 | 1(100.0) |
Bladder Cancer | 1 | 0 | 0 | 0 | 0 |
Primitive neuroectodermal tumor | 1 | 0 | 0 | 0 | 0 |
Tongue cancer | 1 | 0 | 0 | 0 | 0 |
Endometrial cancer | 1 | 1 | 1(100.0) | 0 | 0 |